Along with other COVID‐19 clinical manifestations, management of both olfactory and
gustatory dysfunction have drawn a considerable attention. Photobiomodulation (PBM) has …

It is postulated that the inflammatory process resulting from SARS‐CoV‐2 infection is the
main cause of smell and taste dysfunctions in patients. In view of this, photobiomodulation …

Objective: The aim of this study is to evaluate local and systemic photobiomodulation (PBM)
in patients with COVID-19-related dysgeusia, with the expectation of improving taste …

Olfactory dysfunction is commonly seen in COVID-19 patients; however, little is known about
the pathophysiology and management. The present study aimed to report a series of cases …

Olfactory dysfunction (OD) is a recognized symptom of the severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) and is independently associated with …

A new pandemic was declared at the end of 2019 because of coronavirus disease 2019
(COVID-19). One of the effects of COVID-19 infection is anosmia (ie, a loss of smell) …

There is increasing recognition of post‐COVID‐19 sequelae involving chronic fatigue and
brain fog, for which photobiomodulation (PBM) therapy has been utilized. This open‐label …

The occurrence of anosmia, the loss or change in sense of smell, is one of the most common
symptoms of COVID-19 experienced by almost 53% of those affected. Several hypotheses …

With the evolving understanding of COVID-19, a thorough analysis of the effects of this
unique coronavirus on the affected people's olfactory abilities could highlight the disease's …

Background and aim Among the most common symptoms of COVID-19 is taste dysfunction,
which has a ranging clinical presentation. As well as its pathophysiology remains to be …